Akira Furuta

Dr. Akira Furuta


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
AFAkira Furuta
Akira Furuta
TYTokunori Yamamoto
Tokunori Yamamoto
YSYasuyuki Suzuki
Yasuyuki Suzuki
MGMomokazu Gotoh
Momokazu Gotoh
SEShin Egawa
Shin Egawa
NYNaoki Yoshimura
Naoki Yoshimura

30 May 2019 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
AFAkira Furuta
Akira Furuta
YSYasuyuki Suzuki
Yasuyuki Suzuki
TITaro Igarashi
Taro Igarashi
YKYusuke Koike
Yusuke Koike
TKTakahiro Kimura
Takahiro Kimura
NYNaoki Yoshimura
Naoki Yoshimura
Objectives: To examine the correlation among bladder inflammation, angiogenesis, fibrosis and urothelial denudation in biopsied bladder specimens, and O'Leary‐Sant symptom indexes, O'Leary‐Sant problem indexes and visual analog scale pain scores in interstitial cystitis/bladder pain syndrome patients with or without Hunner lesions (Hunner type interstitial cystitis or non‐Hunner type interstitial cystitis).Methods: Bladder biopsied tissues were collected from 12 Hunner type interstitial cystitis female patients, 12 non‐Hunner type interstitial cystitis female patients and 12 age‐matched non‐interstitial cystitis female patients (controls). Immunohistochemical stainings of tissue necrotic factor‐α, mast cell tryptase, vascular endothelial growth factor, CD31, transforming growth factor‐β, SLUG associated with epithelial mesenchymal transition and E‐cadherin as well as Masson trichrome staining were evaluated. The significant correlation between the expression of tissue necrotic factor‐α, mast cell tryptase, vascular endothelial growth factor, CD31, transforming growth factor‐β, collagen, SLUG or E‐cadherin, and O'Leary‐Sant symptom indexes, O'Leary‐Sant problem indexes or visual analog scale pain scores was then examined.Results: The expression of tissue necrotic factor‐α, vascular endothelial growth factor, CD31, transforming growth factor‐β and SLUG was significantly increased in non‐Hunner type interstitial cystitis and Hunner type interstitial cystitis patients compared with controls whereas the significant increases in the expression of mast cell tryptase and collagen were observed in Hunner type interstitial cystitis patients compared with controls and non‐Hunner type interstitial cystitis patients. On the other hand, the expression of E‐cadherin was significantly decreased in Hunner type interstitial cystitis patients compared with controls and non‐Hunner type interstitial cystitis patients. In addition, the increased expression of CD31 in bladder tissues was strongly correlated with O'Leary‐Sant symptom indexes, O'Leary‐Sant problem indexes and visual analog scale pain scores.Conclusions: These results suggest that bladder angiogenesis evident as the increased expression of CD31 is strongly correlated with urinary frequency and bladder pain in patients with non‐Hunner type interstitial cystitis and Hunner type interstitial cystitis.

6 March 2018 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
AFAkira Furuta
Akira Furuta
TYTokunori Yamamoto
Tokunori Yamamoto
TITaro Igarashi
Taro Igarashi
YSYasuyuki Suzuki
Yasuyuki Suzuki
SEShin Egawa
Shin Egawa
NYNaoki Yoshimura
Naoki Yoshimura

1 March 2009 in Journal of Urology
Verified
Journal Article
Closed access
AFAkira Furuta
Akira Furuta
KAKoji Asano
Koji Asano
SEShin Egawa
Shin Egawa
WGWilliam C. de Groat
William C. de Groat
MCMichael B. Chancellor
Michael B. Chancellor
NYNaoki Yoshimura
Naoki Yoshimura
We investigated the role of alpha(2)-adrenoceptors and glutamate mechanisms in the urethral continence reflex in response to abdominal pressure increases. Under urethane anesthesia external urethral sphincter electromyogram activity was evaluated in spinal cord transected (T8-T9) female rats during lower abdominal wall compression before and after intravenous application of test drugs. The effects of the N-methyl-D-aspartate glutamate receptor antagonist MK-801 (Sigma) or the alpha(2)-adrenoceptor agonist medetomidine (Tocris Cookson, Ellisville, Missouri) (each 0.03, 0.3 and 3 mg/kg intravenously) on external urethral sphincter activity were examined. A 0.3 mg/kg intravenous dose of the alpha(2)-adrenoceptor antagonist idazoxan (Sigma) was then administered before or after the application of 1 mg/kg MK-801 intravenously. In addition, 0.3 mg/kg idazoxan were administered intravenously following the application of 1 mg/kg of the serotonin/norepinephrine reuptake inhibitor duloxetine (Kemprotec, Middlesbrough, United Kingdom) intravenously. MK-801 and medetomidine dose dependently decreased external urethral sphincter activity. Idazoxan significantly increased external urethral sphincter activity by 64% but the increase in activity after idazoxan was abolished by MK-801. On the other hand, idazoxan did not reverse the inhibitory effects of MK-801. In addition, idazoxan significantly potentiated the duloxetine effects on external urethral sphincter activity by 120%. These results indicate that 1) glutamate is a major excitatory neurotransmitter in the urethral continence reflex response to abdominal pressure increases, 2) alpha(2)-adrenoceptor activation suppresses external urethral sphincter activity, probably via presynaptic inhibition of glutamate release and 3) the effects of serotonin/norepinephrine reuptake inhibitors are enhanced by alpha(2)-adrenoceptor inhibition. Therefore, alpha(2)-adrenoceptor antagonists could be beneficial for treating stress urinary incontinence.

21 February 2012 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
AFAkira Furuta
Akira Furuta
YSYasuyuki Suzuki
Yasuyuki Suzuki
NHNorihiro Hayashi
Norihiro Hayashi
SEShin Egawa
Shin Egawa
NYNaoki Yoshimura
Naoki Yoshimura
Although the pathogenesis of interstitial cystitis/bladder pain syndrome remains unknown, there is a significant correlation of interstitial cystitis/bladder pain syndrome with other chronic pain disorders, such as irritable bowel syndrome, endometriosis and fibromyalgia syndrome. In this review, we highlight evidence supporting neural cross‐talk in the dorsal root ganglia, spinal cord and brain levels, which might play a role in the development of chronic pain disorders through central sensitization. In addition, we focus on transient receptor potential V1 and transient receptor potential A1 as the receptor targets for chronic pain conditions, because transient receptor potential V1 and transient receptor potential A1 act as a nocisensor to mediate not only an afferent signal to the dorsal horn of the spinal cord, but also an efferent signal in the periphery through secretion of inflammatory agents, such as substance P and calcitonin gene‐related peptide in nociceptive sensory neurons. Furthermore, peripheral inflammation produces multiple inflammatory mediators that act on their cognate receptors to activate intracellular signal transduction pathways and thereby modify the expression and function of transient receptor potential V1 and transient receptor potential A1 (peripheral sensitization). During tissue damage and inflammation, oxidative stress, such as reactive oxygen species or reactive carbonyl species is also generated endogenously. The highly diffusible nature might account for the actions of free radical formation far from the site of injury, thereby producing systemic pain conditions without central sensitization through neural cross‐talk. Because oxidative stress is considered to induce activation of transient receptor potential A1, we also discuss exogenous and endogenous oxidative stress to elucidate its role in the pathogenesis of interstitial cystitis/bladder pain syndrome and other chronic pain conditions.

6 November 2012 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
YKYusuke Koike
Yusuke Koike
AFAkira Furuta
Akira Furuta
YSYasuyuki Suzuki
Yasuyuki Suzuki
MHMariko Honda
Mariko Honda
TNTakehito Naruoka
Takehito Naruoka
NYNaoki Yoshimura
Naoki Yoshimura
Urethral closure mechanisms under stress conditions consist of passive urethral closure involving connective tissues, fascia and/or ligaments in the pelvis and active urethral closure mediated by hypogastric, pelvic and pudendal nerves. Furthermore, we have previously reported that the active urethral closure mechanism might be divided into two categories: (i) the central nervous control passing onto Onuf's nucleus under sneezing or coughing; and (ii) the bladder‐to‐urethral spinal reflex under Valsalva‐like stress conditions, such as laughing, exercise or lifting heavy objects. There are over 200 million people worldwide with urinary incontinence, a condition that is associated with a significant social impact and reduced quality of life. Therefore, basic research for urinary continence mechanisms in response to different stress conditions can play an essential role in developing treatments for stress urinary incontinence. It has been clinically shown that the etiology of stress urinary incontinence is divided into urethral hypermobility and intrinsic sphincter deficiency, which could respectively correspond to passive and active urethral closure dysfunction. In this review, we summarize the representative stress urinary incontinence animal models and the methods to measure leak point pressures under stress conditions, and then highlight stress‐induced urinary continence mechanisms mediated by active urethral closure mechanisms, as well as future pharmacological treatments of stress urinary incontinence. In addition, we introduce our previous reports including sex differences in urethral closure mechanisms under stress conditions and urethral compensatory mechanisms to maintain urinary continence after pudendal nerve injury in female rats.